title: How animal models of leukaemias have already benefited patients.
abstract: The relative genetic simplicity of leukaemias, the development of which likely relies on a limited number of initiating events has made them ideal for disease modelling, particularly in the mouse. Animal models provide incomparable insights into the mechanisms of leukaemia development and allow exploration of the molecular pillars of disease maintenance, an aspect often biased in cell lines or ex vivo systems. Several of these models, which faithfully recapitulate the characteristics of the human disease, have been used for pre-clinical purposes and have been instrumental in predicting therapy response in patients. We plea for a wider use of genetically defined animal models in the design of clinical trials, with a particular focus on reassessment of existing cancer or non-cancer drugs, alone or in combination.
authors: Université Paris Diderot, Sorbonne Paris Cité, Hôpital St. Louis 1, Avenue Claude Vellefaux, 75475 Paris cedex 10, France.
authors: Julien
authors: J
authors: Ablain
authors: Rihab
authors: R
authors: Nasr
authors: Jun
authors: J
authors: Zhu
authors: Ali
authors: A
authors: Bazarbachi
authors: Valérie
authors: V
authors: Lallemand-Breittenbach
authors: Hugues
authors: H
authors: de Thé
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D006801:Humans; D007938:Leukemia / Q000235:genetics / Q000473:pathology* / Q000628:therapy